Compulsive buying rarely presents as a diagnostically isolated behavioral pattern. Published literature on clinical populations consistently documents high rates of comorbid psychiatric conditions — mood disorders, anxiety disorders, substance use disorders, other impulse-control disorders, and eating disorders all substantially exceeding population base rates. The directional relationships are, in most cases, not established: evidence is insufficient to determine whether comorbid depression, for example, is a vulnerability factor predisposing to compulsive buying, a consequence of its financial and relational consequences, or a co-occurring condition sharing common etiological factors. In clinical practice, all three relationships are plausible in different patients, and accurate formulation requires individual-level assessment rather than assumption.
Depression and anxiety disorders are the most consistently documented comorbidities. The temporal relationship between depressive episodes and buying escalation is bidirectional in many presentations: depressive anhedonia and low mood increase the appeal of buying as a mood-regulatory strategy, while the financial consequences, self-evaluative shame, and relationship consequences of compulsive buying worsen depressive symptomatology. This feedback architecture has the same treatment implication as in other behavioral addictions: addressing depression without addressing compulsive buying leaves the behavioral reinforcer of depression intact; addressing compulsive buying without addressing depression removes the regulatory strategy without improving the underlying state it was regulating.
Anxiety disorders have a clinically relevant relationship with shopping in some patients: the shopping environment provides a structured social context with clearly defined roles (customer, salesperson) that reduces the performance anxiety of less scripted interpersonal encounters. For these patients, shopping may serve a social function alongside its mood-regulatory function — a point that is clinically important when considering the consequences of behavioral reduction.
ADHD has a well-documented and mechanistically coherent relationship with compulsive buying. The core ADHD neuropsychology — impaired inhibitory control, elevated delay discounting, difficulty with financial planning and management, and enhanced sensitivity to immediate reinforcement — maps directly onto the behavioral architecture of compulsive buying. Unidentified and untreated ADHD is a common maintaining factor in treatment-resistant presentations: patients make genuine behavioral change attempts that fail repeatedly not because motivation is insufficient but because the executive function capacities that sustained change requires — planning, inhibitory control, delay tolerance, working memory for financial goals — are specifically impaired. ADHD assessment and treatment is a clinical priority in this population, not a secondary consideration.
The relationship between compulsive buying and OCD requires careful individual formulation. Some presentations involve intrusive buying-related cognitions and compulsive buying acts that reduce distress associated with those cognitions — a presentation with genuine phenomenological overlap with OCD for which exposure and response prevention may be more appropriate than behavioral addiction frameworks. More commonly, compulsive buying lacks the ego-dystonic quality of OCD compulsions and the specific anxiety-neutralization function of OCD rituals.
Binge eating disorder co-occurs with compulsive buying at rates substantially above chance, and the behavioral parallels are more than coincidental: both involve episodic loss of control over consumption behavior in response to negative affect, a dissociative quality during the episode, and post-episode regret and shame. These shared features suggest common underlying mechanisms — negative urgency, impaired inhibitory control, mood-regulatory behavioral dependence — that warrant integrated formulation when both conditions are present.
Whether compulsive buying is best classified as a behavioral addiction, an OCD-spectrum disorder, or an impulse-control disorder is an active and unresolved debate. The addiction model emphasizes craving, relief, escalation, and continued use despite consequences. The OCD-spectrum model emphasizes the intrusive, repetitive, and anxiety-reducing qualities of some presentations. The impulse-control model — increasingly dominant as the nosological home for similarly situated conditions and consistent with ICD-11’s broader approach — centers inhibitory failure without requiring addiction-model neurobiological features.
The honest clinical answer is that compulsive buying likely constitutes a heterogeneous category within which different individuals’ presentations align most closely with different nosological frameworks — and that treatment selection should be guided by individual formulation. The addiction framework’s treatment infrastructure provides genuine clinical value independent of its theoretical accuracy. The impulse-control framework’s emphasis on emotional regulation and inhibitory function has strong mechanistic support. These frameworks are complementary in clinical practice even where they conflict nosologically.
The depression-buying feedback cycle requires simultaneous rather than sequential clinical attention. Treating depression without addressing compulsive buying leaves the behavioral reinforcer intact; treating buying without addressing depression removes the regulatory strategy without improving the underlying state. Integrated treatment is more likely to be effective than prioritizing one condition sequentially. ADHD assessment should be routine in compulsive buying presentations, not reserved for patients who identify attentional symptoms as a primary complaint. The ASRS-v1.1 is brief and has adequate sensitivity for initial screening. A positive screen warrants formal ADHD evaluation before attributing treatment resistance to motivational factors.